课题基金 / 基金详情

项目摘要

项目成果

Alexei Bagrov的其他基金

相似基金

相关文献

中文摘要
翻译
我们研究了16例PE患者(平均BP = 1232 mmHg; 282岁,36周gest。年龄)和14例胎龄匹配的正常妊娠受试者(平均BP = 922 mmHg)。PE与血浆和胎盘MBG水平升高相关。在PE脐动脉中,转录因子和纤维化负调控因子Fli-1的表达显著降低(P<0.001),而前胶原-1的表达增加(P<0.01)。与对照血管相比,PE受试者的脐动脉环对内皮素-1的反应性未发生改变(EC 50分别为2.2和3.2 nmol/L),但对内皮素-1诱导的收缩后硝普钠的舒张作用的反应性受损(EC 50 = 1.5 vs. 32.4 nmol/L P<0.001)。用1和10 nmol/L MBG离体处理正常脐动脉外植体模拟PE的作用,特异性抑制Fli-1并增加胶原-1表达,同时损害血管舒张。我们的研究结果表明,在PE中,MBG水平升高通过Fli-1依赖性机制诱导血管纤维化,导致血管舒张受损,并表明MBG代表了治疗这种综合征的潜在靶点。
英文摘要
We studied 16 patients with PE (mean BP = 1232 mmHg; 282 years, 36 weeks gest. age) and 14 gestational age-matched normal pregnant subjects (mean BP = 922 mmHg). PE was associated with a rise in plasma and placental levels of MBG. In PE umbilical arteries, the expression of Fli-1, a transcription factor and a negative regulator of fibrosis, was significantly reduced (P<0.001), while procollagen-1 expression was increased (P<0.01). As compared to control vessels, isolated rings of umbilical arteries from subjects with PE demonstrated unaltered responsiveness to endothelin-1 (EC50 = 2.2 and 3.2 nmol/L, respectively), but exhibited an impaired response to the relaxant effect of sodium nitroprusside (EC50= 1.5 vs. 32.4 nmol/L P<.001) following endothelin-1-induced constriction. Ex vivo treatment of normal umbilical arteries explants with 1 and 10 nmol/L MBG mimicked the effects of PE, specifically suppressed Fli-1 and increased collagen-1 expression while impairing vasorelaxation. Our results indicate that in PE, elevated levels of MBG induce vascular fibrosis via a Fli-1-dependent mechanism which leads to an impairment of vasorelaxation, and suggest that MBG represents a potential target for therapy of this syndrome.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Aging and interaction of natriuretic factors on renal and vascular sodium pump
  • 批准号:
    8736638
  • 项目类别:
  • 资助金额:
    $41.83万
  • 财政年份:
    --
  • 负责人:
    Alexei Bagrov
  • 依托单位:
Sodium Pump Inhibitors In Blood Pressure Regulation
  • 批准号:
    8736576
  • 项目类别:
  • 资助金额:
    $43.8万
  • 财政年份:
    --
  • 负责人:
    Alexei Bagrov
  • 依托单位:
Marinobufagenin as a therapeutic target
  • 批准号:
    9147364
  • 项目类别:
  • 资助金额:
    $54.3万
  • 财政年份:
    --
  • 负责人:
    Alexei Bagrov
  • 依托单位:
Aging and interaction of natriuretic factors on renal and vascular sodium pump
  • 批准号:
    8335945
  • 项目类别:
  • 资助金额:
    $21.77万
  • 财政年份:
    --
  • 负责人:
    Alexei Bagrov
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: